A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
That is how peptides are best approached: as medicine to be understood, not products to be bought on impulse
Both the Wegovy pill and the Wegovy pen contain the same active ingredient, semaglutide, and are FDA-approved for weight management
For a more detailed breakdown of the costs, have a look at our guide on how much B12 injections cost
You can obtain it from pharmacies, medical supply stores, or online retailers that require a prescription or have specific licensing for its sale